TY - JOUR
T1 - Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature
AU - Nurchis, Mario Cesare
AU - Nurchis, Mario Cesare
AU - Riccardi, Maria Teresa
AU - Damiani, Gianfranco
PY - 2022
Y1 - 2022
N2 - Objective: The aim of this scoping review is to map the available evidence about the use of health technology assessment (HTA) in the assessment of whole genome sequencing (WGS).Methods: A scoping review methodology was adopted. The population, concept, and context framework was used to build up the research question and to establish the eligibility criteria. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews was adopted to implement a comprehensive search strategy. Evidence was retrieved from scientific databases and HTA organizations Web sites. Reports were classified as full HTA, mini-HTA, rapid reviews or other.Results: The search strategy identified seven reports. Five HTA organizations from five countries elaborated the reports: one full HTA, four rapid reviews, and two classified as others. The reports were mainly focused on the evaluation of the clinical utility and cost-effectiveness of genome-wide sequencing as well as informing policy questions by providing analyses of organizational and ethical considerations.Conclusions: Few HTA organizations are drafting reports for WGS. It is essential to stimulate a critical reflection during the elaboration of HTA reports for WGS to steer choices of decision makers in the establishment of priorities for research and policy and reimbursement rates.
AB - Objective: The aim of this scoping review is to map the available evidence about the use of health technology assessment (HTA) in the assessment of whole genome sequencing (WGS).Methods: A scoping review methodology was adopted. The population, concept, and context framework was used to build up the research question and to establish the eligibility criteria. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews was adopted to implement a comprehensive search strategy. Evidence was retrieved from scientific databases and HTA organizations Web sites. Reports were classified as full HTA, mini-HTA, rapid reviews or other.Results: The search strategy identified seven reports. Five HTA organizations from five countries elaborated the reports: one full HTA, four rapid reviews, and two classified as others. The reports were mainly focused on the evaluation of the clinical utility and cost-effectiveness of genome-wide sequencing as well as informing policy questions by providing analyses of organizational and ethical considerations.Conclusions: Few HTA organizations are drafting reports for WGS. It is essential to stimulate a critical reflection during the elaboration of HTA reports for WGS to steer choices of decision makers in the establishment of priorities for research and policy and reimbursement rates.
KW - Cost-Benefit Analysis
KW - Evidence-based decisions
KW - Health policy
KW - Health technology assessment
KW - Technology Assessment, Biomedical
KW - Whole Genome Sequencing
KW - Whole genome sequencing
KW - Cost-Benefit Analysis
KW - Evidence-based decisions
KW - Health policy
KW - Health technology assessment
KW - Technology Assessment, Biomedical
KW - Whole Genome Sequencing
KW - Whole genome sequencing
UR - http://hdl.handle.net/10807/214914
U2 - 10.1017/S0266462322000496
DO - 10.1017/S0266462322000496
M3 - Article
SN - 0266-4623
VL - 38
SP - e71-N/A
JO - International Journal of Technology Assessment in Health Care
JF - International Journal of Technology Assessment in Health Care
ER -